The labels of your outsourcing facility 's compounded drug products do not include information required by section 503B(a)(l O)(A).
Inspection Record
SSM Health Care St. Louis DBA SSM St. Clare Health Center — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The responsibilities and procedures are not in writing and fully followed.
The 100% visual check is not conducted with a contrasting background but held up to the light or held near the back where the HEPA filter in the ISO 5 IV Hood is located for the darker background (observed on 8/6/2014).
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the equipment to produce aseptic conditions where compounding activities occur.
You failed to have a smoke study procedure used to evaluate your ISO 5 IV hood under dynamic conditions and you have not conducted a smoke study since the IV hood was installed in 2009.
Procedures designed to prevent microbiological contamination of compounded drug products purporting to be sterile are not followed.
All batch product records from April 14 – August 6, 2014 are inadequate for the compounded products listed above.
You have failed to conduct Environmental Monitoring in you ISO 5, IV rooms (where drug products are c ompounded).
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Leiter's Enterprises, Inc. dba Leiter's2018-10-24 · US FDASimilar to finding 6 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed.
- Gilead Sciences Inc.2015-07-17 · US FDASimilar to finding 6 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed.
- Zydus Lifesciences Limited2025-09-05 · US FDASimilar to finding 4 Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the equipment to produce aseptic conditions.
- Able Laboratories, Inc.2015-07-24 · US FDASimilar to finding 2 The responsibilities and procedures to the quality control unit are not in writing and fully followed.
- Absolute Pharmacy LLC2016-05-18 · US FDASimilar to finding 6 Procedures designed to prevent microbiological contamination ofdrug products purporting to be sterile are not established, written, and followed.
A record as of the US FDA document published on 2024-01-17. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.